genedrive plc (LON:GDR – Get Free Report)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 1.19 and traded as low as GBX 1.15. genedrive shares last traded at GBX 1.22, with a volume of 5,948,941 shares changing hands.
genedrive Price Performance
The company has a debt-to-equity ratio of -120.48, a current ratio of 0.99 and a quick ratio of 5.52. The stock has a 50 day moving average price of GBX 1.19 and a 200-day moving average price of GBX 1.10. The stock has a market capitalization of £18.77 million, a price-to-earnings ratio of -1.48 and a beta of 0.99.
genedrive Company Profile
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Recommended Stories
- Five stocks we like better than genedrive
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
